As total shoulder arthroplasty (TSA) expands to younger patients, it is crucial to weigh the benefits of early intervention against potential complications and implant longevity in patients under 60 years of age. This study examines mid-term outcomes in this patient subset. Between 2009 and 2019, a retrospective analysis was conducted on 50 patients (25 male, 25 female) who underwent anatomic TSA (TSA) under the age of 60 with minimum 5 years follow-up. Demographic and baseline variables were extracted from medical records. Pre-operative and post-operative outcomes of range of motion (ROM) and strength were recorded. Patient-reported outcomes (PROs) were obtained. Fifty patients were followed for an average of 8.7 ± 2.4 years, having a mean age of 54.1 ± 8.4 years. Comparison of pre-operative and post-operative measurements revealed significant improvements in active ROM, including external rotation (ER) (p < 0.0001), forward elevation (FE) (p < 0.0001), and internal rotation (IR) (p = 0.0001). There were significant improvements in functional strength scores, including ER (p = 0.0005) and FE (p = 0.0002). PROs included visual analog scale (VAS) (2.2 ± 2.6), Single Assessment Numeric Evaluation (SANE) (80.3 ± 17.6), American Shoulder and Elbow Surgeons (ASES) score (76.4 ± 22.8), and Simple Shoulder Test (SST) (8.9 ± 3.2). The 5-year and 10-year implant survival rates were found to be 98.0 % and 83.3 %, respectively. There were 7 postoperative complications in 5 patients (14.0 %), including glenoid loosening (n = 2), infection (n = 1), atraumatic instability (n = 1), lesser tuberosity avulsion (n = 1), painful arthroplasty (n = 1) and traumatic rotator cuff insufficiency (n = 1). Subsequently, all 5 patients underwent revision shoulder arthroplasty at an average of 6.5 years after the initial procedure. Positive mid to long-term outcomes, including significant improvements in ROM and strength, along with high 5-year and 10-year implant survival rates support TSA as an effective treatment option for patients under the age of 60.
The utility of reverse total shoulder arthroplasty (RTSA) has evolved to accommodate many complex shoulder pathologies including proximal humerus fractures (PHFs) and fracture sequelae. Within our aging population, PHFs are occurring at higher rates than ever before. Literature assessing differences in clinical and functional following RTSA for PHF and rotator cuff arthropathy (RCA) is limited. This study aims examine outcomes after RTSA for PHF and RCA at 2-years follow-up. Records of who underwent RTSA for PHF and RCA at our institution between July 1, 2009 to October 1, 2019 with a 2-year minimum follow-up were retrospectively analyzed. Patient demographic information, postoperative functional measurements, and complications were collected. A 5-year Kaplan-Meier survival analysis was performed. Overall, 23 patients underwent RTSA for fracture and 123 for RCA. Fracture patients showed significantly worse forward elevation (128.9° ± 38.8° vs 141.9° ± 21.1°; p-value = 0.0242). No differences were observed in range of motion or strength for external rotation and internal rotation, as well as patient-reported outcome measures. Fracture patients showed a complication rate of 9.1 % and an implant survival rate of 78.0 % after 5 years. RCA patients experienced a 7.4 % complication rate and a 91.5 % survival rate after 5 years. RTSA has been shown to restore shoulder functionality in patients with complex PHFs. In this study, RTSA for fracture resulted in similar functionality, complication rates, and implant longevity when compared to elective indications.